Back

Targeted screening for transthyretin cardiac amyloidosis in severe aortic stenosis: development and validation of a clinical risk score

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: New insights into diagnosis of cardiac amyloidosis Restrictive Cardiomyopathy and Loeffler´s Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alexios Antonopoulos

Hippokration General Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Diverse anatomical and metabolic effects of amyloid deposits in transthyretin cardiac amyloidosis revealed by 3D reconstruction of serial block face-scanning electron microscopy images
Doctor S. Saito (Shimotsuke, JP)
Abstract Slides
Presentation thumbnail
Trajectory and prognostic significance of conduction system disease in cardiac transthyretin amyloidosis: a european multicenter cohort study
Doctor L. Schlender (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Prognostic implications of Perugini Grading in a contemporary centre referral cohort undergoing evaluation for suspected cardiac amyloidosis
Ms N. Hartvig Jensen (DK)
Abstract Slides
Presentation thumbnail
Multimodal assessment of disease progression risk among transthyretin amyloid cardiomyopathy patients under disease-modifying therapy
Doctor J. Groeschel (Berlin, DE)
Abstract Slides
Presentation thumbnail
Heterogeneity in cardiac amyloidosis care across Europe: a key opinion leader survey
Mr L. Kieviet (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
New insights into diagnosis of cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a single center experience
29 August 2022
thumbnail
Congress Presentation
Risk prediction in patients with classical Low-flow, low-gradient aortic stenosis undergoing TAVI
29 August 2021
thumbnail
Congress Presentation
Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters
20 June 2025
thumbnail
Congress Presentation
External validation of the Mayo Clinc ATTR-CM score in the HFpEF population
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources